Trials / Unknown
UnknownNCT01985594
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
STUDY ON EFFICACY OF UTROGESTAN AS TOCOLYSIS FOR PRETERM LABOR
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- nor zila hassan malek · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
RESEARCH HYPOTHESIS -Incidence of preterm delivery is lower in women treated with oral micronized progesterone (Utrogestan) as acute tocolysis agent compare to Nifedipine group with fewer maternal side effect
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | utrogestan | Oral Tablet Utrogestan 400 mg daily for 2 days |
| DRUG | Nifedipine | Tablet Nifedipine 20 mg stat then 20 mg after 30 minutes if contraction persist and another 20mg after 30 minutes if contraction still persist followed by 10 mg three times daily for 2 days |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-07-01
- Completion
- 2014-10-01
- First posted
- 2013-11-15
- Last updated
- 2013-11-15
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT01985594. Inclusion in this directory is not an endorsement.